Ulla Derhaschnig

2.3k total citations
69 papers, 1.7k citations indexed

About

Ulla Derhaschnig is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Immunology. According to data from OpenAlex, Ulla Derhaschnig has authored 69 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 21 papers in Hematology and 13 papers in Immunology. Recurrent topics in Ulla Derhaschnig's work include Platelet Disorders and Treatments (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Acute Myocardial Infarction Research (11 papers). Ulla Derhaschnig is often cited by papers focused on Platelet Disorders and Treatments (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (15 papers) and Acute Myocardial Infarction Research (11 papers). Ulla Derhaschnig collaborates with scholars based in Austria, Germany and United Kingdom. Ulla Derhaschnig's co-authors include Bernd Jilma, Christian Schoergenhofer, Michael Schwameis, Eva‐Luise Hobl, Michael M. Hirschl, Claudia Marsik, Petra Jilma‐Stohlawetz, Thomas Stimpfl, Christian Woisetschläger and Harald Herkner and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Ulla Derhaschnig

68 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ulla Derhaschnig Austria	26	675	380	304	277	268	69	1.7k
Eric T.T.L. Tjwa Netherlands	22	304 0.5×	137 0.4×	680 2.2×	261 0.9×	761 2.8×	67	1.9k
T. Andrea United States	23	329 0.5×	253 0.7×	653 2.1×	359 1.3×	200 0.7×	94	2.1k
Yoke Lin Fung Australia	24	160 0.2×	335 0.9×	242 0.8×	594 2.1×	221 0.8×	89	2.1k
Eduardo Ramacciotti United States	24	549 0.8×	321 0.8×	345 1.1×	103 0.4×	73 0.3×	82	1.4k
David E. Joyce United States	13	184 0.3×	741 1.9×	227 0.7×	334 1.2×	809 3.0×	20	2.0k
Joseph D. Sweeney United States	25	178 0.3×	833 2.2×	194 0.6×	118 0.4×	78 0.3×	106	1.8k
A. van den Ende Netherlands	16	153 0.2×	301 0.8×	290 1.0×	186 0.7×	174 0.6×	42	1.4k
Ioanna Koniari Greece	20	565 0.8×	49 0.1×	346 1.1×	194 0.7×	232 0.9×	100	1.5k
Minoru Ando Japan	25	124 0.2×	268 0.7×	265 0.9×	185 0.7×	219 0.8×	99	1.6k
Barry Wenz United States	24	163 0.2×	569 1.5×	209 0.7×	162 0.6×	199 0.7×	71	1.5k

Countries citing papers authored by Ulla Derhaschnig

Since Specialization

Citations

This map shows the geographic impact of Ulla Derhaschnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Derhaschnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Derhaschnig more than expected).

Fields of papers citing papers by Ulla Derhaschnig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Derhaschnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Derhaschnig. The network helps show where Ulla Derhaschnig may publish in the future.

Co-authorship network of co-authors of Ulla Derhaschnig

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Derhaschnig. A scholar is included among the top collaborators of Ulla Derhaschnig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Derhaschnig. Ulla Derhaschnig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wagner, Laura Danielle, Romana Hochreiter, Santhosh Kumar Ghadge, et al.. (2025). Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 25(9). 986–999. 4 indexed citations

Wagner, Laura Danielle, Romana Hochreiter, Julian Larcher‐Senn, et al.. (2025). Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 26(3). 314–328. 1 indexed citations

Thalhammer, Renate, Christian Sillaber, Ulla Derhaschnig, et al.. (2024). Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial. Frontiers in Medicine. 11. 1481333–1481333. 2 indexed citations

Ay, Cihan, Ingrid Pabinger, Georg Gelbenegger, et al.. (2022). The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Advances. 6(18). 5467–5476. 20 indexed citations

Ay, Cihan, Christian Schoergenhofer, Georg Gelbenegger, et al.. (2022). The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A. Blood. 141(10). 1147–1158. 18 indexed citations

Grafeneder, Juergen, Ulla Derhaschnig, Farsad Eskandary, et al.. (2022). Micellar Curcumin: Pharmacokinetics and Effects on Inflammation Markers and PCSK‐9 Concentrations in Healthy Subjects in a Double‐Blind, Randomized, Active‐Controlled, Crossover Trial. Molecular Nutrition & Food Research. 66(22). e2200139–e2200139. 10 indexed citations

Schoergenhofer, Christian, Nina Buchtele, Georg Gelbenegger, et al.. (2019). Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers. Scientific Reports. 9(1). 11136–11136. 8 indexed citations

Derhaschnig, Ulla, Christian Schoergenhofer, Christa Firbas, et al.. (2019). Specific Inhibition of the Classical Complement Pathway Prevents C3 Deposition along the Dermal-Epidermal Junction in Bullous Pemphigoid. Journal of Investigative Dermatology. 139(12). 2417–2424.e2. 26 indexed citations

Derhaschnig, Ulla, et al.. (2016). Combined integrated protocol/basket trial design for a first-in-human trial. Orphanet Journal of Rare Diseases. 11(1). 134–134. 27 indexed citations

10.

Knappe, Sabine, Bernd Jilma, Ulla Derhaschnig, et al.. (2013). Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood. Thrombosis and Haemostasis. 109(3). 450–457. 19 indexed citations

11.

Hobl, Eva‐Luise, Thomas Stimpfl, Josef Ebner, et al.. (2013). Morphine Decreases Clopidogrel Concentrations and Effects. Journal of the American College of Cardiology. 63(7). 630–635. 146 indexed citations

12.

Spiel, Alexander, et al.. (2010). Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy. Critical Care Medicine. 38(6). 1423–1429. 13 indexed citations

13.

Derhaschnig, Ulla & Bernd Jilma. (2009). Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes – is there a future?. Thrombosis and Haemostasis. 102(12). 1144–1148. 10 indexed citations

14.

Hirschl, Michael M., et al.. (2007). Effects of Candesartan and Lisinopril on the Fibrinolytic System in Hypertensive Patients. Journal of Clinical Hypertension. 9(6). 430–435. 5 indexed citations

15.

Woisetschläger, Christian, et al.. (2006). Comparison of intravenous urapidil and oral captopril in patients with hypertensive urgencies. Journal of Human Hypertension. 20(9). 707–709. 9 indexed citations

16.

Kellett, John, Michael M. Hirschl, Ulla Derhaschnig, et al.. (2004). Bedside Testing of Cardiac Troponin T and Myoglobin for the Detection of Acute Myocardial Infarction in Patients with a Nondiagnostic Electrocardiogram in the Emergency Department. Point of Care The Journal of Near-Patient Testing & Technology. 3(4). 159–161. 2 indexed citations

17.

Derhaschnig, Ulla, et al.. (2004). Variable inhibition of high-shear–induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von willebrand release: a randomized, placebo-controlled, clinical trial. American Heart Journal. 147(4). 697–697. 28 indexed citations

18.

Reiter, Rosemarie, Ulla Derhaschnig, Alexander Spiel, et al.. (2003). Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans. Thrombosis and Haemostasis. 90(11). 898–903. 30 indexed citations

19.

Sunder‐Plassmann, Gere, Harald Kittler, Michael M. Hirschl, et al.. (2002). Angiotensin converting enzyme DD genotype is associated with hypertensive crisis*. Critical Care Medicine. 30(10). 2236–2241. 18 indexed citations

20.

Collinson, Paul, Bo Jørgensen, Christer Sylvén, et al.. (2001). Recalibration of the point-of-care test for CARDIAC T Quantitative with Elecsys Troponin T 3rd generation. Clinica Chimica Acta. 307(1-2). 197–203. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact